MarketWatch

Vittoria Biotherapeutics Announces Presentation of First-in-Human Interim Phase1 Data for VIPER-101 at ASH2025

The MarketWatch News Department was not involved in the creation of this content. PHILADELPHIA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company ...
Kotaku

Arcade Archives: Viper Phase 1

All the Latest Game Footage and Images from Arcade Archives: Viper Phase 1 Heroes will surely return. Carrying the hope of the entire galaxy. Advertisement All the Latest Game Footage and Images from ...
MarketWatch

Vittoria Biotherapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of VIPER-101

Trial is evaluating VIPER-101, a novel, gene edited, autologous dual-population CAR-T therapy in patients with T cell lymphoma VIPER-101 was developed with Vittoria's proprietary Senza5 platform that ...
Business Insider

Vittoria Biotherapeutics Announces Presentation of First-in-Human Interim Phase1 Data for VIPER-101 at ASH2025

PHILADELPHIA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company pioneering innovative cell therapies, today announced it will share interim ...